BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report issued to clients and investors on Friday. The firm set a “sell” rating on the medical technology company’s stock.

BIOLASE Stock Performance

Shares of BIOL opened at $0.01 on Friday. The company has a market capitalization of $260,574.60, a PE ratio of 0.00 and a beta of 0.67. The company’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.01. BIOLASE has a 52 week low of $0.02 and a 52 week high of $1.94.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.